Middle East: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2022

Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in the Middle East

The Middle Eastern market for hormones, prostaglandins, thromboxanes and leukotrienes surged to $X in 2021, growing by X% against the previous year. The total consumption indicated a resilient expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption decreased by -X% against 2017 indices. The level of consumption peaked at $X in 2017; however, from 2018 to 2021, consumption failed to regain momentum.

Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in the Middle East

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production dropped slightly to $X in 2021 estimated in export price. The total production indicated buoyant growth from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production decreased by -X% against 2017 indices. The growth pace was the most rapid in 2015 when the production volume increased by X% against the previous year. The level of production peaked at $X in 2020, and then reduced slightly in the following year.

Production By Country in the Middle East

The countries with the highest volumes of in 2021 were Saudi Arabia (X tons), Israel (X tons) and the United Arab Emirates (X tons).

From 2012 to 2021, the biggest increases were in Saudi Arabia (with a CAGR of +X%), while production for the other leaders experienced more modest paces of growth.

Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Exports in the Middle East

In 2021, overseas shipments of hormones, prostaglandins, thromboxanes and leukotrienes decreased by -X% to X tons for the first time since 2017, thus ending a three-year rising trend. Over the period under review, exports, however, saw buoyant growth. The pace of growth was the most pronounced in 2020 with an increase of X%. As a result, the exports attained the peak of X tons, and then dropped in the following year.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports rose notably to $X in 2021. Overall, exports recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2015 when exports increased by X%. As a result, the exports reached the peak of $X. From 2016 to 2021, the growth of the exports remained at a lower figure.

Exports by Country

In 2021, Israel (X tons) represented the major exporter of hormones, prostaglandins, thromboxanes and leukotrienes, generating X% of total exports. It was distantly followed by Turkey (X tons), comprising an X% share of total exports. Jordan (X tons), the United Arab Emirates (X tons), Oman (X tons) and Saudi Arabia (X tons) took a minor share of total exports.

From 2012 to 2021, average annual rates of growth with regard to hormones, prostaglandins, thromboxanes and leukotrienes exports from Israel stood at +X%. At the same time, Oman (+X%), Turkey (+X%), the United Arab Emirates (+X%) and Jordan (+X%) displayed positive paces of growth. Moreover, Oman emerged as the fastest-growing exporter exported in the Middle East, with a CAGR of +X% from 2012-2021. By contrast, Saudi Arabia (-X%) illustrated a downward trend over the same period. While the share of Turkey (+X p.p.) and Oman (+X p.p.) increased significantly in terms of the total exports from 2012-2021, the share of the United Arab Emirates (-X p.p.), Jordan (-X p.p.) and Saudi Arabia (-X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Israel ($X) remains the largest hormones, prostaglandins, thromboxanes and leukotrienes supplier in the Middle East, comprising X% of total exports. The second position in the ranking was taken by the United Arab Emirates ($X), with a X% share of total exports. It was followed by Jordan, with a X% share.

From 2012 to 2021, the average annual growth rate of value in Israel stood at -X%. The remaining exporting countries recorded the following average annual rates of exports growth: the United Arab Emirates (+X% per year) and Jordan (+X% per year).

Export Prices by Country

The leukotrienes in the Middle East stood at $X per ton in 2021, rising by X% against the previous year. Overall, the export price, however, recorded a deep setback. The most prominent rate of growth was recorded in 2017 an increase of X%. The level of export peaked at $X per ton in 2012; however, from 2013 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was the United Arab Emirates ($X per ton), while Turkey ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Saudi Arabia (+X%), while the other leaders experienced more modest paces of growth.

Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Imports in the Middle East

In 2021, approx. X tons of hormones, prostaglandins, thromboxanes and leukotrienes were imported in the Middle East; jumping by X% on the year before. The total import volume increased at an average annual rate of +X% from 2012 to 2021; the trend pattern remained consistent, with only minor fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2019 when imports increased by X%. Over the period under review, imports hit record highs in 2021 and are likely to see steady growth in the near future.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports expanded remarkably to $X in 2021. The total import value increased at an average annual rate of +X% from 2012 to 2021; the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2017 with an increase of X% against the previous year. Over the period under review, imports attained the peak figure in 2021 and are likely to continue growth in the near future.

Imports by Country

In 2021, Iran (X tons) was the largest importer of hormones, prostaglandins, thromboxanes and leukotrienes, achieving X% of total imports. It was distantly followed by Turkey (X tons), Jordan (X tons), the United Arab Emirates (X tons), Oman (X tons) and Israel (X tons), together generating a X% share of total imports. Iraq (X tons) followed a long way behind the leaders.

Imports into Iran increased at an average annual rate of +X% from 2012 to 2021. At the same time, Oman (+X%), Iraq (+X%), Turkey (+X%), Jordan (+X%) and the United Arab Emirates (+X%) displayed positive paces of growth. Moreover, Oman emerged as the fastest-growing importer imported in the Middle East, with a CAGR of +X% from 2012-2021. By contrast, Israel (-X%) illustrated a downward trend over the same period. While the share of Iran (+X p.p.), Turkey (+X p.p.), Oman (+X p.p.), Jordan (+X p.p.), Iraq (+X p.p.) and the United Arab Emirates (+X p.p.) increased significantly in terms of the total imports from 2012-2021, the share of Israel (-X p.p.) displayed negative dynamics.

In value terms, Iran ($X), Turkey ($X) and Israel ($X) appeared to be the countries with the highest levels of imports in 2021, with a combined X% share of total imports. These countries were followed by the United Arab Emirates, Jordan, Oman and Iraq, which together accounted for a further X the main importing countries, Oman, with a CAGR of +X%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the leukotrienes in the Middle East amounted to $X per ton, with a decrease of -X% against the previous year. Over the period from 2012 to 2021, it increased at an average annual rate of +X%. The pace of growth was the most pronounced in 2020 an increase of X%. As a result, import price reached the peak level of $X per ton, and then dropped in the following year.

Prices varied noticeably by the country of destination: the country with the highest price was Israel ($X per ton), while Iraq ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United Arab Emirates (+X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform